Table 2 The operative characteristics of patients compared by use of DHCA
Variable | DHCA | P | |
|---|---|---|---|
No | Yes | ||
Operative duration,min | 0.00 | ||
n | 12 | 21 | |
Mean(median) | 267.9(96.7) | 521.9(120.6) | |
EBL,ml | 0.01 | ||
n | 12 | 21 | |
Mean(median) | 854.3(863.8) | 5933.7(8040) | |
Transfusions,n | |||
n | 5 | 21 | |
Mean(median) | 4.8(3.1) | 17.22(11.67) | |
ICU stay,days | |||
n | 1 | 21 | |
Mean(median) | 6 | 6.4(1.3) | |
Hospital stay,days | 0.00 | ||
n | 12 | 33 | |
Mean(median) | 13.8(4.4) | 28.5(14.3) | |
Perioperative mortality,n | 0.58 | ||
n | 12 | 21 | |
N(%)deaths | 0 | 1(4.7) | |
Tumor pathology | |||
renal clear cell carcinoma | 5(41.7) | 8(38.1) | |
renal cell carcinoma | 3(0.25) | 5(23.8) | |
adrenocortical | 2(16.7) | 4(19.0) | |
Whilms tumor | 2(16.7) | 3(14.3) | |
renal pelvic transitional carcinoma | 0 | 1(4.7) | |